Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Array BioPharma To Report Financial Results For The First Quarter Of Fiscal 2017 On November 1, 2016

Array BioPharma
Posted on: 26 Oct 16

BOULDER, Colo., Oct. 25, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq:  ARRY) will report financial results for the first quarter of fiscal 2017 and hold a conference call to discuss those results on Tuesday, November 1, 2016. Ron Squarer, Chief Executive Officer, will lead the call.

Date:               

Tuesday, November 1, 2016

Time:              

9:00 a.m. Eastern Time

Toll-Free:        

(844) 464-3927

Toll:                

(765) 507-2598

Pass Code:      

93600421

Webcast, including Replay and Conference Call Slides: 
http://edge.media-server.com/m/p/8qcss7h2

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Five registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca).

CONTACT:       

Tricia Haugeto                          

 

Array BioPharma Inc.

 

(303) 386-1193

 

thaugeto@arraybiopharma.com

For more information:
finance.yahoo.com/news/array-biopharma-report-financial-results-150000921.html

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 26/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.